Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing pet ownership
3.2.1.2 Growing incidence of canine diseases
3.2.1.3 Expanding awareness of early vaccination
3.2.2 Industry pitfalls & challenges
3.2.2.1 Adverse effects and the hesitancy for the vaccination
3.2.2.2 Stringent regulatory requirements
3.3 Growth potential analysis
3.4 Pipeline analysis
3.5 Future market trends
3.6 Regulatory landscape
3.7 Porter's anlaysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Live attenuated
5.3 Inactivated
5.4 Recombinant
5.5 Other vaccine types
Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Canine distemper
6.3 Canine infectious respiratory disease complex (CIRDC)
6.4 Canine parvovirus
6.5 Canine leptospirosis
6.6 Canine lyme disease
6.7 Infectious canine hepatitis
6.8 Canine rabies
6.9 Other disease types
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Intranasal
7.3 Injectable
7.4 Oral
Chapter 8 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Veterinary hospitals
8.3 Veterinary clinics
8.4 Research institutes
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Bioveta, a.s.
10.2 Boehringer Ingelheim International GmbH
10.3 Brilliant Bio Pharma
10.4 Creative Biolabs
10.5 Elanco Animal Health Incorporated
10.6 Merck & Co., Inc.
10.7 NEOTECH, LLC
10.8 Virbac
10.9 Zendal Group
10.10 Zoetis Inc.
